Insulin Dosing Calculator for Type 2 Diabetes
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, since participants must be receiving insulin therapy prior to admission, it seems likely that you will continue your current insulin regimen.
What data supports the idea that Insulin Dosing Calculator for Type 2 Diabetes is an effective treatment?
The available research shows that insulin dosing calculators are effective in improving blood sugar control and patient safety. For example, one study found that integrating an insulin calculator into hospital systems helped improve patient care by ensuring timely insulin administration and better matching insulin doses with meals. Another study highlighted that these calculators are useful in managing insulin doses for patients after cardiac surgery, suggesting they help maintain stable blood sugar levels. Overall, these tools help reduce human error in insulin dosing, making them a reliable option for managing diabetes.12345
What safety data exists for the insulin dosing calculator for type 2 diabetes?
The safety data for insulin dosing calculators, including those used in different settings, suggest they improve patient safety and glycemic control. Studies have shown that these calculators, when integrated into electronic health records, help reduce errors in insulin dosing by providing a structured approach to dose calculation. They have been used effectively in both pediatric and adult hospital settings, with benefits such as improved patient education and workflow. However, challenges in implementation and integration have been noted, which require careful management to avoid potential pitfalls.12367
Is the Insulin Dosing Calculator for Type 2 Diabetes a promising treatment?
Yes, the Insulin Dosing Calculator for Type 2 Diabetes is a promising treatment. It helps doctors and patients manage insulin doses more accurately, reducing the chance of errors. This tool can improve patient care by making it easier to adjust insulin levels based on individual needs and food intake. It also integrates with electronic health records, making it convenient for hospital use.13489
What is the purpose of this trial?
The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main questions it aims to answer are:* Whether using this calculator leads to no excessive hypoglycemia?* Whether using this calculator leads to a decrease of hyperglycemia?Participants will receive initial insulin doses by the calculator on hospital admission, and the rest of care will follow standard of care. Participants will be compared with patients in the UW observational cohort who received initial insulin doses by standard of care.
Research Team
Hou-Hsien Chiang, MD, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for patients admitted to the University of Washington Medical Centers who have type 2 or steroid-induced diabetes mellitus and were on insulin therapy before admission. It's not suitable for individuals outside these criteria.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive initial insulin doses by the calculator on hospital admission
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Initial insulin dosing using the calculator
Initial insulin dosing using the calculator is already approved in United States, European Union, Canada for the following indications:
- Type 2 diabetes mellitus
- Type 2 diabetes mellitus
- Type 2 diabetes mellitus
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator